Hamilton Crowne Plaza Hotel
1001 14th Street, NW
Washington, DC 20005
Wednesday, August 20
9:00 – 9:15 a.m. Welcome and Opening Remarks
Amy Gutmann, Ph.D.
Commission Chair
James Wagner, Ph.D.
Commission Vice Chair
9:15 – 10:30 a.m. Session 1: Ethical Considerations in Cognitive Enhancement
Peter Reiner, V.M.D., Ph.D.
Professor, National Core for Neuroethics
Kinsmen Laboratory of Neurological Research and Brain Research Centre, Department of Psychiatry
University of British Columbia
Rear Admiral Peter J. Delany, Ph.D., LCSW-C
Director, Center for Behavioral Health Statistics and Quality
Substance Abuse and Mental Health Services Administration
Adrian Raine, Ph.D.
Richard Perry University Professor of Criminology, Psychiatry, and Psychology
University of Pennsylvania
Nick Bostrom, Ph.D.
Professor, Faculty of Philosophy
Director, Future of Humanity Institute
Director, Programme on the Impacts of Future Technology
University of Oxford
10:30 – 10:45 a.m. Break
10:45 a.m. – 12:00 p.m. Session 2: Direct-to-Consumer Neurotechnology
John Reppas, M.D., Ph.D.
Director of Public Policy
Neurotechnology Industry Organization
Carlos Peña, Ph.D., M.S.
Director, Division of Neurological and Physical Medicine Devices
Office of Device Evaluation
Center for Devices and Radiological Health
U.S. Food and Drug Administration
Freddie Ann Hoffman, M.D.
Chief Executive Officer and Founding Member
HeteroGeneity LLC
Former Deputy Director, Medicine Staff
Office of the Commissioner
U.S. Food and Drug Administration
Deven McGraw, J.D., M.P.H., LL.M.
Partner, Manatt, Phelps & Phillips, LLP
Former Director, Health Privacy Project
Center for Democracy and Technology
12:00 – 1:15 p.m. Lunch Break
1:15 – 2:15 p.m. Session 3: Neuroscience Research – Clinical Innovation and Applications
Steven L. Small, Ph.D., M.D.
Stanley van den Noort Professor and Chair,
Department of Neurology
Professor of Neurobiology and Behavior
Professor of Cognitive Sciences
Director, Neuroscience Imaging Center
University of California, Irvine
Professor Emeritus of Neurology,
The University of Chicago
Paul J. Ford, Ph.D.
Program Director, NeuroEthics Program
Education Director, Department of Bioethics
Cleveland Clinic
Associate Professor, Division of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Helen Mayberg, M.D.
Professor of Psychiatry, Neurology, and Radiology
Dorothy C. Fuqua Chair, Psychiatric Neuroimaging and Therapeutics
Emory University School of Medicine
2:15 – 3:00 p.m. Session 4: Neuroscience Research and Diminished Capacity
Jerry Menikoff, M.D., J.D.
Director, Office for Human Research Protections
U.S. Department of Health and Human Services
Paul S. Appelbaum, M.D.
Elizabeth K. Dollard Professor of Psychiatry, Medicine & Law
Director, Division of Psychiatry, Law, and Ethics
Director, Center for Research on Ethical, Legal & Social Implications of Psychiatric, Neurologic & Behavioral Genetics
Department of Psychiatry
Columbia University
3:00 – 3:15 p.m. Break
3:15 – 4:45 p.m. Session 5: Roundtable Discussion
4:45 – 5:00 p.m. Concluding Remarks
Amy Gutmann, Ph.D.
James Wagner, Ph.D.
